Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Philip, Boehme"'
Autor:
Florian Dahlhausen, Maximillian Zinner, Linn Bieske, Jan P Ehlers, Philip Boehme, Leonard Fehring
Publikováno v:
Digital Health, Vol 8 (2022)
Background Mobile health applications and their subset digital therapeutics—defined as evidence-based software interventions to prevent, manage, or treat a medical condition—offer great potential to improve patient care. However, such solutions o
Externí odkaz:
https://doaj.org/article/9e04aa627b8f4b228e6fc9baf0e1107f
Autor:
Florian Dahlhausen, Maximillian Zinner, Linn Bieske, Jan P Ehlers, Philip Boehme, Leonard Fehring
Publikováno v:
JMIR mHealth and uHealth, Vol 9, Iss 11, p e33012 (2021)
BackgroundIn October 2020, Germany became the first country, worldwide, to approve certain mobile health (mHealth) apps, referred to as DiGA (Digitale Gesundheitsanwendungen, in German, meaning digital health applications), for prescription with cost
Externí odkaz:
https://doaj.org/article/f67a1dfee06c4d99a3ef9a5e1ab282b4
Autor:
Wenli Zhang, Jun Fu, Jing Liu, Hailong Wang, Maren Schiwon, Sebastian Janz, Lukas Schaffarczyk, Lukas von der Goltz, Eric Ehrke-Schulz, Johannes Dörner, Manish Solanki, Philip Boehme, Thorsten Bergmann, Andre Lieber, Chris Lauber, Andreas Dahl, Andreas Petzold, Youming Zhang, A. Francis Stewart, Anja Ehrhardt
Publikováno v:
Cell Reports, Vol 19, Iss 8, Pp 1698-1709 (2017)
Adenoviruses (Ads) are large human-pathogenic double-stranded DNA (dsDNA) viruses presenting an enormous natural diversity associated with a broad variety of diseases. However, only a small fraction of adenoviruses has been explored in basic virology
Externí odkaz:
https://doaj.org/article/05491b28e9a94eaaac46bab0120beb0a
Publikováno v:
Research in Social and Administrative Pharmacy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7998ae3157a2496d109631192ad314a5
https://doi.org/10.1016/j.sapharm.2023.05.007
https://doi.org/10.1016/j.sapharm.2023.05.007
Publikováno v:
MMW - Fortschritte der Medizin. 164:3-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fed7ec5588dad5e84b8f7d8917f01f2d
https://doi.org/10.1007/s15006-022-0854-7
https://doi.org/10.1007/s15006-022-0854-7
Publikováno v:
Der Urologe. 60:1570-1578
Zusammenfassung Hintergrund Die neuen Gesetze zur Organspende von 2019 und 2020 umfassen Regelungen zur Steigerung der Organspenderate. Dazu zählen Strukturverbesserungen, die Einführung eines Online-Registers zur Dokumentation der Entscheidung zur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6d6c15e7d16ad8415e0cae8a8b16ba3
https://doi.org/10.1007/s00120-021-01645-y
https://doi.org/10.1007/s00120-021-01645-y
Autor:
Michael Coll Barroso, Philip Boehme, Frank Kramer, Thomas Mondritzki, Till Koehler, Jan-Erik Gülker, Martin Karoff, Wilfried Dinh
Publikováno v:
Arquivos Brasileiros de Cardiologia, Iss 0 (2017)
Abstract Background: Endostatin is a circulating endogenous angiogenesis inhibitor preventing neovascularization. Previous studies demonstrated the prognostic value of Endostatin among patients with heart failure with reduced ejection fraction (HFrEF
Externí odkaz:
https://doaj.org/article/4045f4c146564adcb821c8c5073d9cdf
Autor:
Alexander Schmidt, Jakob Balitzki, Ljubica Grmaca, Julia Vogel, Philip Boehme, Katharina Boden, Jörg Hüser, Hubert Truebel, Thomas Mondritzki
Publikováno v:
Heart failure reviews.
Innovations in the development of novel heart failure therapies are essential to further increase the predictive value of early research findings. Animal models are still playing a pivotal role in ‘translational research’. In recent years, the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34e130583f707a8f62a46dca9fe74f2
https://pubmed.ncbi.nlm.nih.gov/36001250
https://pubmed.ncbi.nlm.nih.gov/36001250
Publikováno v:
MMW Fortschritte der MedizinLiteratur. 164(Suppl 6)
According to the new legislation on organ donation in Germany, general practitioners (GPs) should regularly inform and educate their patients about organ donation from March 1, 2022. This is because of the persistently low organ donation rate in Germ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c32cf0e1b2c4fd769521f5cfe3bf38e6
https://pubmed.ncbi.nlm.nih.gov/35449486
https://pubmed.ncbi.nlm.nih.gov/35449486
Publikováno v:
Drug Discovery Today. 28:103421
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c97ccf0717fb5184f8c34329e5c37dc
https://doi.org/10.1016/j.drudis.2022.103421
https://doi.org/10.1016/j.drudis.2022.103421